Atlas Trials

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Clinical trial NCT06871839 · RECRUITING

Trial details

NCT number
NCT06871839
Sponsor
Cuibai Wei,Clinical Professor
Status
RECRUITING
Study type
OBSERVATIONAL
Alzheimer's DiseaseLecanemabFunctional Magnetic Resonance Imaging
Start date
2025-03-10
Primary completion
2026-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.